tiprankstipranks
Oncimmune Holdings PLC (GB:ONC)
LSE:ONC

Oncimmune Holdings Financial Statements

0 Followers

Oncimmune Holdings Financial Overview

Oncimmune Holdings's market cap is currently ―. The company's EPS TTM is p-0.137; its P/E ratio is -5.52; Oncimmune Holdings is scheduled to report earnings on November 3, 2022, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
May 22Nov 21May 21Nov 20May 20
Income Statement
Total Revenue£ ―£ ―£ ―£ ―£ ―
Gross Profit£ ―£ ―£ ―£ ―£ ―
EBIT£ ―£ ―£ ―£ ―£ ―
EBITDA£ ―£ ―£ ―£ ―£ ―
Net Income Common Stockholders£ ―£ ―£ ―£ ―£ ―
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments£ 2.53M£ 2.96M£ 3.28M£ 4.24M£ 5.36M
Total Assets£ 17.26M£ 18.18M£ 24.28M£ 9.59M£ 10.31M
Total Debt£ 0.00£ 3.56M£ 6.26M£ 8.57M£ 9.47M
Net Debt£ -2.53M£ 590.00K£ 2.98M£ 4.33M£ 4.11M
Total Liabilities£ 19.98M£ 16.95M£ 19.05M£ 12.02M£ 10.51M
Stockholders Equity£ 1.23M£ 2.29M£ 5.23M£ 7.87M£ -2.73M
Cash Flow
Free Cash Flow£ ―£ ―£ ―£ ―£ ―
Operating Cash Flow£ ―£ ―£ ―£ ―£ ―
Investing Cash Flow£ ―£ ―£ ―£ ―£ ―
Financing Cash Flow£ ―£ ―£ ―£ ―£ ―
Currency in GBP

Oncimmune Holdings Earnings and Revenue History


Oncimmune Holdings Debt to Assets


Oncimmune Holdings Cash Flow


Oncimmune Holdings Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis